DE138713C - - Google Patents
Info
- Publication number
- DE138713C DE138713C DENDAT138713D DE138713DA DE138713C DE 138713 C DE138713 C DE 138713C DE NDAT138713 D DENDAT138713 D DE NDAT138713D DE 138713D A DE138713D A DE 138713DA DE 138713 C DE138713 C DE 138713C
- Authority
- DE
- Germany
- Prior art keywords
- bismuth
- acid
- oxyiodide
- agaric
- basic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- HZLCGUXUOFWCCN-UHFFFAOYSA-N 2-hydroxynonadecane-1,2,3-tricarboxylic acid Chemical compound CCCCCCCCCCCCCCCCC(C(O)=O)C(O)(C(O)=O)CC(O)=O HZLCGUXUOFWCCN-UHFFFAOYSA-N 0.000 claims description 20
- CBACFHTXHGHTMH-UHFFFAOYSA-N 2-piperidin-1-ylethyl 2-phenyl-2-piperidin-1-ylacetate;dihydrochloride Chemical compound Cl.Cl.C1CCCCN1C(C=1C=CC=CC=1)C(=O)OCCN1CCCCC1 CBACFHTXHGHTMH-UHFFFAOYSA-N 0.000 claims description 16
- 229910052797 bismuth Inorganic materials 0.000 claims description 10
- 229940040563 agaric acid Drugs 0.000 claims description 9
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 claims description 9
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims description 6
- 229910000043 hydrogen iodide Inorganic materials 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000003513 alkali Substances 0.000 claims 1
- 239000002253 acid Substances 0.000 description 10
- 150000007513 acids Chemical class 0.000 description 7
- 150000001621 bismuth Chemical class 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- RXPAJWPEYBDXOG-UHFFFAOYSA-N hydron;methyl 4-methoxypyridine-2-carboxylate;chloride Chemical compound Cl.COC(=O)C1=CC(OC)=CC=N1 RXPAJWPEYBDXOG-UHFFFAOYSA-N 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- -1 acids Bismuth salts Chemical class 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- CBIXFXPGRXJEAJ-UHFFFAOYSA-N [I].[Bi] Chemical compound [I].[Bi] CBIXFXPGRXJEAJ-UHFFFAOYSA-N 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- ZREIPSZUJIFJNP-UHFFFAOYSA-K bismuth subsalicylate Chemical compound C1=CC=C2O[Bi](O)OC(=O)C2=C1 ZREIPSZUJIFJNP-UHFFFAOYSA-K 0.000 description 1
- BJINYZHIGSHXEP-UHFFFAOYSA-N bismuth;iodo hypoiodite Chemical class [Bi].IOI BJINYZHIGSHXEP-UHFFFAOYSA-N 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 229910000039 hydrogen halide Inorganic materials 0.000 description 1
- 239000012433 hydrogen halide Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- SAYWRBWZPUHRGX-UHFFFAOYSA-M iodobismuth Chemical class [Bi]I SAYWRBWZPUHRGX-UHFFFAOYSA-M 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229940079877 pyrogallol Drugs 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/94—Bismuth compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE138713C true DE138713C (cg-RX-API-DMAC7.html) |
Family
ID=406502
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DENDAT138713D Active DE138713C (cg-RX-API-DMAC7.html) |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE138713C (cg-RX-API-DMAC7.html) |
-
0
- DE DENDAT138713D patent/DE138713C/de active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE138713C (cg-RX-API-DMAC7.html) | ||
| DE2751590C2 (de) | Verfahren zur Verbesserung der Dispergierbarkeit von natürlichem Gummi | |
| DE2126127A1 (de) | Tris-(hydroxymethyl)-aminomethansalze von Prostaglandinen | |
| DE938502C (de) | Verfahren zur Herstellung einer kolloidalen Eisenzubereitung | |
| DE1794368B2 (de) | Organische saure Lösungen von basischen Farbstoffen | |
| DE1965384A1 (de) | Verfahren zur Herstellung von p-Nitroso- und p-Nitrophenolen | |
| AT262325B (de) | Verfahren zur Herstellung von neuen organischen Salzen des D-Glucosamins, dessen Stickstoff mit α-Ketosäuren quaternisiert ist | |
| DE221112C (cg-RX-API-DMAC7.html) | ||
| DE438906C (de) | Verfahren zur Gewinnung in Wasser unloeslicher bzw. wenig loeslicher Stoffe in Form von klaren, waesserigen Loesungen oder von klar wasserloeslichen Trockenpraeparaten | |
| DE165898C (cg-RX-API-DMAC7.html) | ||
| DE330815C (de) | Verfahren zur Herstellung von wasserloeslichen Eiseneiweissverbindungen | |
| DE128854C (cg-RX-API-DMAC7.html) | ||
| DE579224C (de) | Verfahren zur Darstellung von jodierten Abkoemmlingen des 4-Pyridons | |
| DE343150C (de) | Verfahren zur Darstellung von Salzen der Verbindungen von Gerbsaeuren oder Gallussaeure und Milchsaeure | |
| DE74322C (de) | Verfahren zur Herstellung einer leicht löslichen Eisenmaltose | |
| DE188435C (cg-RX-API-DMAC7.html) | ||
| DE58614C (de) | Verfahren zur Darstellung einer Amidonaphtoxylessigsäure und einer Sulfosäure derselben | |
| DE165807C (cg-RX-API-DMAC7.html) | ||
| DE2132863C3 (de) | Feststoffgemisch und daraus hergestellte Lösung zum Sensibilisieren von Oberflächen für die stromlose Metallabscheidung sowie Verfahren zu dessen Herstellung | |
| DE258297C (cg-RX-API-DMAC7.html) | ||
| DE1695035C3 (de) | Verfahren zur Herstellung von 5-Chlor-2,3-pyridindiol | |
| DE2238761C3 (de) | Verfahren zur Herstellung 2substituierter 5-Benzothiazol-essigsäure-Verbindungen | |
| DE2312460C3 (de) | Verfahren zur Herstellung von 3-Acetamido-5-aminobenzoesaure | |
| AT160388B (de) | Verfahren zur Herstellung wasserfreier therapeutisch wirksamer Metalloleosole. | |
| DE267411C (cg-RX-API-DMAC7.html) |